Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections

Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) (NIH)
Overall Status
Completed
CT.gov ID
NCT00004996
Collaborator
(none)
90
1
181.1
0.5

Study Details

Study Description

Brief Summary

This study will compare the structure, chemical composition and other characteristics of skin and blood in people with and without parasitic infections. Cell samples will be taken from blisters produced by suction blistering. This study may provide new information about the interactions between parasites and the immune system that could lead to better treatments for these infections.

Normal volunteers and patients with acute helminth (a type of parasite) infections aged 18 years older may be eligible for this study. Following a medical history and physical exam, participants will undergo suction blistering to provide cells needed for study. A suction blister device is attached to the skin of the thigh. A heating element in the device heats the skin to speed blister formation. (This will feel only a slightly warm.) The device is removed after about two hours, when the blisters have formed. The blister tops are removed with sterile scissors. The blistered areas are then treated with special dressings to promote healing and the participant is discharged with further wound care instructions. A small amount of blood (around four tablespoons) may be drawn to compare chemicals in the blood with chemicals in the blister fluid. Participants will be contacted by telephone over the next 72 hours to check on healing. Further follow-up will occur by phone at 6 months and 1 year.

Up to 60 blisters may be produced over a one-year period (in three separate sessions every six months) with no more than 20 raised per session....

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This study will compare the structure, chemical composition and other characteristics of skin and blood in people with and without parasitic infections. Cell samples will be taken from blisters produced by suction blistering. This study may provide new information about the interactions between parasites and the immune system that could lead to better treatments for these infections.

    Normal volunteers and patients with acute helminth (a type of parasite) infections aged 18 years older may be eligible for this study. Following a medical history and physical exam, participants will undergo suction blistering to provide cells needed for study. A suction blister device is attached to the skin of the thigh. A heating element in the device heats the skin to speed blister formation. (This will feel only a slightly warm.) The device is removed after about two hours, when the blisters have formed. The blister tops are removed with sterile scissors. The blistered areas are then treated with special dressings to promote healing and the participant is discharged with further wound care instructions. A small amount of blood (around four tablespoons) may be drawn to compare chemicals in the blood with chemicals in the blister fluid. Participants will be contacted by telephone over the next 72 hours to check on healing. Further follow-up will occur by phone at 6 months and 1 year.

    Up to 60 blisters may be produced over a one-year period (in three separate sessions every six months) with no more than 20 raised per session.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    90 participants
    Official Title:
    Langherhans' Cell Function and Inflammatory Responses in Skin of Volunteers Using the Suction Blister Technique
    Study Start Date :
    Mar 20, 2000
    Study Completion Date :
    Apr 22, 2015

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 65 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      • INCLUSION CRITERIA:
      1. Between the ages of 18 and 65 years inclusive

      2. Access to a primary medical care provider outside of the NIH

      3. Able to give informed consent

      4. Willingness to have history and physical examination annually

      EXCLUSION CRITERIA:
      1. History of malignancy or autoimmune disease such as rheumatoid arthritis, vasculitis, pyoderma gangrenosum

      2. Use of systemic corticosteroids within the past month

      3. Use of local corticosteroids at the proposed blistering site within the past month

      4. Evidence of current acute infection

      5. Personal or family history of keloid formation

      6. Use of any investigative drugs within the past month

      7. History of skin disease within the past one year (e.g. psoriasis, atopic dermatitis)

      8. History of diabetes

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda Maryland United States 20892

      Sponsors and Collaborators

      • National Institute of Allergy and Infectious Diseases (NIAID)

      Investigators

      • Principal Investigator: Thomas B Nutman, M.D., National Institute of Allergy and Infectious Diseases (NIAID)

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      Responsible Party:
      National Institute of Allergy and Infectious Diseases (NIAID)
      ClinicalTrials.gov Identifier:
      NCT00004996
      Other Study ID Numbers:
      • 000099
      • 00-I-0099
      First Posted:
      Mar 23, 2000
      Last Update Posted:
      Dec 12, 2019
      Last Verified:
      Apr 22, 2015
      Keywords provided by National Institute of Allergy and Infectious Diseases (NIAID)
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Dec 12, 2019